23andMe SPAC Presentation Deck

>>> >>> »»>> >>> Systematic, Scalable Research Platform Yields Novel Drug Targets Phenotypic Data 10,000's of Genome-Wide Association Study (GWAS) Hits Determine Disease Associated Genes and Directionality Genetic Data Researching to Understand Compelling Biology Identifying Druggable Proteins Phenome-Wide Association Studies (PheWAS) Reveal Additional Indications and Potential Safety Concerns Assessment of Unmet Need and Competitive Landscape Best Drug Targets Wet lab validated targets progress through standard stages of research toward the selection of preclinical lead molecules and clinical development 23andMe's database yields thousands of potential new drug targets Advanced biology and medicinal chemistry guide design of optimal compounds from initial targets Phenotypic breadth provides unique ability to uncover potential safety issues or possible indication expansions 23and Me Confidential and Proprietary Information 25

View entire presentation